Journal
INTERNATIONAL WOUND JOURNAL
Volume 13, Issue 5, Pages 636-644Publisher
WILEY
DOI: 10.1111/iwj.12336
Keywords
17 beta-Estradiol; Ageing; Cutaneous wound healing; Female mice; Ovariectomy
Categories
Funding
- JSPS KAKENHI [22592363, 25293430]
- Kanazawa University
- Grants-in-Aid for Scientific Research [25293430, 22592363] Funding Source: KAKEN
Ask authors/readers for more resources
This study investigated the effect of 17 beta-estradiol on wound healing in 40-week ovariectomised female mice. Thirty-six-week-old female mice were divided into three groups: medication with 17 beta-estradiol after ovariectomy (OVX+17 beta-estradiol), ovariectomy (OVX) and sham (SHAM). The mice received two full-thickness wounds, and the OVX+17 beta-estradiol group was administered 17 beta-estradiol at 0.01 g/day until healing. In the OVX+17 beta-estradiol group, the ratio of wound area was significantly smaller than those of the OVX and SHAM groups on days 1-3, 5, 6, 8-12 and 9-12, respectively, the numbers of neutrophils and macrophages were significantly smaller than those on days 3 and 7, the ratio of re-epithelialisation was significantly higher than those on days 3 and 11, the ratio of myofibroblasts was significantly higher than those on day 11 and smaller on day 14, and the ratio of collagen fibres was significantly larger than that of the OVX group on days 7-14. We found that 17 beta-estradiol administration promotes cutaneous wound healing in 40-week female mice by reducing wound area, shortening inflammatory response, and promoting re-epithelialisation, collagen deposition and wound contraction. Our results suggest that cutaneous wound healing that is delayed because of ageing is promoted by exogenous and continuous 17 beta-estradiol administration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available